Skip to main content
. 2018 Jan 16;4(2):143–144. doi: 10.1016/j.jdcr.2017.11.020

Table I.

Timeline of failed therapies secondary to poor response or complication before dupilumab

Date of therapy Therapy
Before 7/18/16 Methotrexate, cyclosporine, tofacitinib, topical corticosteroids
7/18/2016–7/26/2016 Cyclosporine
Before first appointment–11/22/2016 Prednisone
7/26/2016–8/30/2016 Adalimumab
8/16/2016–9/15/2016 Ustekinumab
8/30/2016–9/15/2016 Apremilast
10/11/2016–4/5/2017 Secukinumab

Secukinumab was discontinued and dupilumab was initiated 4/5/2017.